
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in genome editing through control of DNA repair pathways
Charles D. Yeh, Chris D. Richardson, Jacob E. Corn
Nature Cell Biology (2019) Vol. 21, Iss. 12, pp. 1468-1478
Closed Access | Times Cited: 343
Charles D. Yeh, Chris D. Richardson, Jacob E. Corn
Nature Cell Biology (2019) Vol. 21, Iss. 12, pp. 1468-1478
Closed Access | Times Cited: 343
Showing 1-25 of 343 citing articles:
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Andrew V. Anzalone, Luke W. Koblan, David R. Liu
Nature Biotechnology (2020) Vol. 38, Iss. 7, pp. 824-844
Closed Access | Times Cited: 1787
Andrew V. Anzalone, Luke W. Koblan, David R. Liu
Nature Biotechnology (2020) Vol. 38, Iss. 7, pp. 824-844
Closed Access | Times Cited: 1787
CRISPR technology: A decade of genome editing is only the beginning
Joy Y. Wang, Jennifer A. Doudna
Science (2023) Vol. 379, Iss. 6629
Closed Access | Times Cited: 608
Joy Y. Wang, Jennifer A. Doudna
Science (2023) Vol. 379, Iss. 6629
Closed Access | Times Cited: 608
Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing
James K. Nuñez, Chen Jin, Greg C. Pommier, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2503-2519.e17
Open Access | Times Cited: 514
James K. Nuñez, Chen Jin, Greg C. Pommier, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2503-2519.e17
Open Access | Times Cited: 514
CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
Dan Wang, Feng Zhang, Guangping Gao
Cell (2020) Vol. 181, Iss. 1, pp. 136-150
Open Access | Times Cited: 391
Dan Wang, Feng Zhang, Guangping Gao
Cell (2020) Vol. 181, Iss. 1, pp. 136-150
Open Access | Times Cited: 391
Base editing: advances and therapeutic opportunities
Elizabeth M. Porto, Alexis C. Komor, Ian M. Slaymaker, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 12, pp. 839-859
Open Access | Times Cited: 347
Elizabeth M. Porto, Alexis C. Komor, Ian M. Slaymaker, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 12, pp. 839-859
Open Access | Times Cited: 347
PnB Designer: a web application to design prime and base editor guide RNAs for animals and plants
Sebastian M. Siegner, Mehmet E. Karasu, Markus Schröder, et al.
BMC Bioinformatics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 333
Sebastian M. Siegner, Mehmet E. Karasu, Markus Schröder, et al.
BMC Bioinformatics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 333
DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing
Chaoyou Xue, Eric C. Greene
Trends in Genetics (2021) Vol. 37, Iss. 7, pp. 639-656
Open Access | Times Cited: 258
Chaoyou Xue, Eric C. Greene
Trends in Genetics (2021) Vol. 37, Iss. 7, pp. 639-656
Open Access | Times Cited: 258
Polymeric Delivery of Therapeutic Nucleic Acids
Ramya Kumar, Cristiam F. Santa Chalarca, Matthew R. Bockman, et al.
Chemical Reviews (2021) Vol. 121, Iss. 18, pp. 11527-11652
Closed Access | Times Cited: 253
Ramya Kumar, Cristiam F. Santa Chalarca, Matthew R. Bockman, et al.
Chemical Reviews (2021) Vol. 121, Iss. 18, pp. 11527-11652
Closed Access | Times Cited: 253
A new era in functional genomics screens
Laralynne Przybyla, Luke A. Gilbert
Nature Reviews Genetics (2021) Vol. 23, Iss. 2, pp. 89-103
Closed Access | Times Cited: 182
Laralynne Przybyla, Luke A. Gilbert
Nature Reviews Genetics (2021) Vol. 23, Iss. 2, pp. 89-103
Closed Access | Times Cited: 182
Gene Therapy in Cancer Treatment: Why Go Nano?
Catarina Roma‐Rodrigues, Lorenzo Rivas-García, Pedro V. Baptista, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 233-233
Open Access | Times Cited: 177
Catarina Roma‐Rodrigues, Lorenzo Rivas-García, Pedro V. Baptista, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 233-233
Open Access | Times Cited: 177
Impact of chromatin context on Cas9-induced DNA double-strand break repair pathway balance
Ruben Schep, Eva K. Brinkman, Christ Leemans, et al.
Molecular Cell (2021) Vol. 81, Iss. 10, pp. 2216-2230.e10
Open Access | Times Cited: 166
Ruben Schep, Eva K. Brinkman, Christ Leemans, et al.
Molecular Cell (2021) Vol. 81, Iss. 10, pp. 2216-2230.e10
Open Access | Times Cited: 166
CRISPR-based genome editing through the lens of DNA repair
Tarun S. Nambiar, Lou Baudrier, Pierre Billon, et al.
Molecular Cell (2022) Vol. 82, Iss. 2, pp. 348-388
Open Access | Times Cited: 154
Tarun S. Nambiar, Lou Baudrier, Pierre Billon, et al.
Molecular Cell (2022) Vol. 82, Iss. 2, pp. 348-388
Open Access | Times Cited: 154
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
Samuele Ferrari, Aurélien Jacob, Stefano Beretta, et al.
Nature Biotechnology (2020) Vol. 38, Iss. 11, pp. 1298-1308
Open Access | Times Cited: 148
Samuele Ferrari, Aurélien Jacob, Stefano Beretta, et al.
Nature Biotechnology (2020) Vol. 38, Iss. 11, pp. 1298-1308
Open Access | Times Cited: 148
Deletion and replacement of long genomic sequences using prime editing
Tingting Jiang, Xiao‐Ou Zhang, Zhiping Weng, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 2, pp. 227-234
Open Access | Times Cited: 145
Tingting Jiang, Xiao‐Ou Zhang, Zhiping Weng, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 2, pp. 227-234
Open Access | Times Cited: 145
High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails
Brian R. Shy, Vivasvan S. Vykunta, Alvin Ha, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 4, pp. 521-531
Open Access | Times Cited: 142
Brian R. Shy, Vivasvan S. Vykunta, Alvin Ha, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 4, pp. 521-531
Open Access | Times Cited: 142
Past, present, and future of CRISPR genome editing technologies
Martin Pacesa, Oana Pelea, Martin Jínek
Cell (2024) Vol. 187, Iss. 5, pp. 1076-1100
Open Access | Times Cited: 131
Martin Pacesa, Oana Pelea, Martin Jínek
Cell (2024) Vol. 187, Iss. 5, pp. 1076-1100
Open Access | Times Cited: 131
Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair
Joana Ferreira da Silva, Gonçalo P. Oliveira, E. A. Arasa-Verge, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 126
Joana Ferreira da Silva, Gonçalo P. Oliveira, E. A. Arasa-Verge, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 126
Precision genome editing using cytosine and adenine base editors in mammalian cells
Tony P. Huang, Gregory A. Newby, David R. Liu
Nature Protocols (2021) Vol. 16, Iss. 2, pp. 1089-1128
Closed Access | Times Cited: 121
Tony P. Huang, Gregory A. Newby, David R. Liu
Nature Protocols (2021) Vol. 16, Iss. 2, pp. 1089-1128
Closed Access | Times Cited: 121
CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research
Yue Yang, Jin Xu, Shuyu Ge, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 117
Yue Yang, Jin Xu, Shuyu Ge, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 117
The NIH Somatic Cell Genome Editing program
Krishanu Saha, Erik J. Sontheimer, Philip J. Brooks, et al.
Nature (2021) Vol. 592, Iss. 7853, pp. 195-204
Open Access | Times Cited: 107
Krishanu Saha, Erik J. Sontheimer, Philip J. Brooks, et al.
Nature (2021) Vol. 592, Iss. 7853, pp. 195-204
Open Access | Times Cited: 107
Human embryonic genome activation initiates at the one-cell stage
Maki Asami, Brian Lam, Marcella Ma, et al.
Cell stem cell (2021) Vol. 29, Iss. 2, pp. 209-216.e4
Open Access | Times Cited: 104
Maki Asami, Brian Lam, Marcella Ma, et al.
Cell stem cell (2021) Vol. 29, Iss. 2, pp. 209-216.e4
Open Access | Times Cited: 104
Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing
Jianli Tao, Daniel E. Bauer, Roberto Chiarle
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 104
Jianli Tao, Daniel E. Bauer, Roberto Chiarle
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 104
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
Connor A. Tsuchida, Nadav Brandes, Raymund Bueno, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4567-4582.e20
Open Access | Times Cited: 93
Connor A. Tsuchida, Nadav Brandes, Raymund Bueno, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4567-4582.e20
Open Access | Times Cited: 93
Prime editing: advances and therapeutic applications
Zhihan Zhao, Peng Shang, Prarthana Mohanraju, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 8, pp. 1000-1012
Open Access | Times Cited: 90
Zhihan Zhao, Peng Shang, Prarthana Mohanraju, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 8, pp. 1000-1012
Open Access | Times Cited: 90
CRISPR technologies for genome, epigenome and transcriptome editing
Lukas Villiger, Julia Joung, Luke W. Koblan, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 464-487
Closed Access | Times Cited: 73
Lukas Villiger, Julia Joung, Luke W. Koblan, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 464-487
Closed Access | Times Cited: 73